SCHEMBL997055

SCHEMBL997055

[c]1scc2ncccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL994997 0.65
SCHEMBL2869075 0.65
SCHEMBL30099834 0.64 ALDH1A1 (0.67)
SCHEMBL8194 0.64 ALDH1A1 (0.67)
SCHEMBL18594 0.62 ALDH1A1 (0.44)
SCHEMBL275756 0.62 MAPT (0.41)
Hydrochloric Acid SCHEMBL3710107 0.61 ALDH1A1 (0.63)
Hydrochloric Acid SCHEMBL3704751 0.61 ALDH1A1 (0.63)
Hydrogen Sulfide SCHEMBL29184282 0.61 ALDH1A1 (0.63)
Hydrochloric Acid SCHEMBL3439030 0.61 ALDH1A1 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997011936-A1 PREPARATION OF CARBOXYALKYL DERIVATIVES MERCK & CO., INC. (US) 1997-04-03 WO claimed
CN-111225672-A Mevalonate pathway inhibitors and pharmaceutical compositions thereof 清华大学 2020-06-02 CN disclosed
US-8153634-B2 Carbinol derivatives having cyclic linker KOWA COMPANY, LTD. (JP) 2012-04-10 US disclosed
US-8008306-B2 Quinoline compounds KOWA COMPANY, LTD. (JP) 2011-08-30 US disclosed
EP-2281817-A1 SUBSTITUTED CARBINOL COMPOUND HAVING CYCLIC LINKER Kowa Company, Ltd. (JP) 2011-02-09 EP disclosed
EP-2272843-A1 QUINOLINE COMPOUND Kowa Company, Ltd. (JP) 2011-01-12 EP disclosed
US-20100048610-A1 CARBINOL DERIVATIVES HAVING CYCLIC LINKER KOWA COMPANY, LTD. (JP) 2010-02-25 US disclosed
US-20100016327-A1 QUINOLINE COMPOUNDS KOWA COMPANY, LTD. (JP) 2010-01-21 US disclosed
US-5574070-A Substituted guanidines having high binding to the sigma receptor and the use thereof STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY (US) 1996-11-12 US disclosed
WO-1995029689-A1 N-CARBOXYALKYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS MERCK & CO., INC. (US) 1995-11-09 WO disclosed